Amicogen, Inc. (KOSDAQ:092040)
South Korea · Delayed Price · Currency is KRW 1,865.00
-25.00 (-1.32%)
Apr 29, 2026, 11:50 AM KST
Amicogen Income Statement
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Revenue | 41,981 | 173,605 | 159,904 | 144,296 | 124,881 |
Other Revenue | - | - | -0 | - | - |
| 41,981 | 173,605 | 159,904 | 144,296 | 124,881 | |
Revenue Growth (YoY) | -75.82% | 8.57% | 10.82% | 15.55% | 7.79% |
Cost of Revenue | 36,692 | 123,396 | 105,270 | 98,534 | 80,240 |
Gross Profit | 5,290 | 50,209 | 54,634 | 45,762 | 44,641 |
Selling, General & Admin | 11,814 | 38,247 | 32,987 | 33,513 | 33,632 |
Research & Development | 7,446 | 12,608 | 13,783 | 12,436 | 10,843 |
Amortization of Goodwill & Intangibles | 1,726 | 727.15 | 1,081 | 1,142 | 926.73 |
Other Operating Expenses | 538.81 | 1,856 | 1,749 | 1,112 | 1,505 |
Operating Expenses | 20,664 | 59,772 | 53,945 | 50,688 | 49,269 |
Operating Income | -15,375 | -9,563 | 689.42 | -4,926 | -4,627 |
Interest Expense | -7,754 | -10,241 | -11,335 | -7,460 | -2,949 |
Interest & Investment Income | 250.65 | 533.63 | 498.38 | 412.85 | 349.29 |
Currency Exchange Gain (Loss) | -1,592 | 1,851 | 109.35 | 168.28 | 1,232 |
Other Non Operating Income (Expenses) | -3,022 | 4,942 | 4,470 | 10,422 | 4,325 |
EBT Excluding Unusual Items | -27,492 | -12,477 | -5,569 | -1,382 | -1,670 |
Impairment of Goodwill | - | - | - | -2,428 | -1,028 |
Gain (Loss) on Sale of Investments | -3,515 | -38,812 | -20,962 | -45,437 | 15,200 |
Gain (Loss) on Sale of Assets | 1,649 | 3,911 | -220.91 | 152.5 | -733.06 |
Asset Writedown | - | -5.81 | -3,059 | -1,476 | -2,106 |
Other Unusual Items | -516.94 | -3,156 | 6,581 | - | - |
Pretax Income | -29,875 | -50,539 | -23,230 | -50,571 | 9,663 |
Income Tax Expense | 491.17 | 343.34 | -2,540 | -4,780 | 4,923 |
Earnings From Continuing Operations | -30,366 | -50,883 | -20,690 | -45,791 | 4,741 |
Minority Interest in Earnings | 406.34 | -1,908 | -2,599 | -1,429 | -1,008 |
Net Income | -29,960 | -52,791 | -23,289 | -47,220 | 3,733 |
Net Income to Common | -29,960 | -52,791 | -23,289 | -47,220 | 3,733 |
Net Income Growth | - | - | - | - | -88.19% |
Shares Outstanding (Basic) | 55 | 55 | 40 | 39 | 39 |
Shares Outstanding (Diluted) | 55 | 55 | 40 | 39 | 39 |
Shares Change (YoY) | 0.44% | 37.66% | 2.05% | 0.71% | 1.01% |
EPS (Basic) | -543.00 | -961.00 | -583.58 | -1207.54 | 96.24 |
EPS (Diluted) | -543.00 | -961.00 | -583.58 | -1207.54 | 96.00 |
EPS Growth | - | - | - | - | -88.32% |
Free Cash Flow | -28,132 | -61,017 | -53,873 | -68,338 | -39,235 |
Free Cash Flow Per Share | -509.88 | -1110.74 | -1349.97 | -1747.59 | -1010.49 |
Gross Margin | 12.60% | 28.92% | 34.17% | 31.71% | 35.75% |
Operating Margin | -36.62% | -5.51% | 0.43% | -3.41% | -3.71% |
Profit Margin | -71.36% | -30.41% | -14.56% | -32.72% | 2.99% |
Free Cash Flow Margin | -67.01% | -35.15% | -33.69% | -47.36% | -31.42% |
EBITDA | -5,744 | 4,391 | 13,953 | 7,739 | 6,143 |
EBITDA Margin | -13.68% | 2.53% | 8.73% | 5.36% | 4.92% |
D&A For EBITDA | 9,631 | 13,954 | 13,264 | 12,665 | 10,771 |
EBIT | -15,375 | -9,563 | 689.42 | -4,926 | -4,627 |
EBIT Margin | -36.62% | -5.51% | 0.43% | -3.41% | -3.71% |
Effective Tax Rate | - | - | - | - | 50.94% |
Advertising Expenses | 177.45 | 1,832 | 1,512 | 2,533 | 1,464 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.